EyeCyte Company
EyeCyte is engaged in the development of therapeutics for the treatment of neovascular and degenerative retinal diseases.
Industry:
PharmTech
Technology:
Small Molecules
Funding Status:
Early Stage Venture
Investment Stage:
N/A
Estimated Revenue:
$1M to $10M
Investors Number:
1
Headquarters:
La Jolla, California, United States
Employee Number:
1-10
Number Of Exists:
N/A
Investor Type:
N/A
Total Funding:
$3M
Founded Date:
2005
Last Funding Type:
Series A